Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/3/2020
SIETES contiene 92954 citas

 
 
 1 a 20 de 31 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Télithromycine: bilan des effets indésirables. Prescrire 2014;34:512-5. [Ref.ID 98075]
2. Cita con resumen
Anónimo. Tobramycin in inhalation powder (Tobi Podhaler) for cystic fibrosis. Med Lett Drugs Ther 2013;55:51-2. [Ref.ID 95931]
3.Enlace a cita original
Anónimo. Vismodegib approved for basal cell carcinoma. WHO Drug Information 2013;27:114. [Ref.ID 95813]
4.
Bascones-Martínez A, Muñoz-Corcuera M, Gómez-Font R. Efectos secundarios bucales de la radioterapia y quimioterapia en el cáncer en la región cervicofacial. Med Clin (Barc) 2013;141:77-81. [Ref.ID 95765]
5. Cita con resumen
Anónimo. Two new drugs for weight loss. Med Lett Drugs Ther 2012;43:69-71. [Ref.ID 93703]
6. Cita con resumen
Anónimo. FDA approves Cometriq to treat rare type of thyroid cancer. U.S. Food and Drug Administration 2012:29 de noviembre. [Ref.ID 93268]
7.
Rowe IA, Mutimer DJ. Protease inhibitors for treatment of genotype 1 hepatitis C virus infection. BMJ 2011;343:1060-3. [Ref.ID 91842]
8.Enlace a cita original Cita con resumen
Garjón Parra J. ¿Y si fuera el medicamento? Síntomas comunes que pueden deberse a reacciones adversas. Boletín de Información Farmacoterapéutica de Navarra 2011;19:17-27. [Ref.ID 91190]
9. Cita con resumen
Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, Bonaiuti R, Antonioli L, Fornai M, Giustarini G, Scollo C, Corona T, Ferrazin F, Sottosanti L, Blandizzi C. Drug-induced taste and smell alterations: a case/non-case evaluation on an Italian Database of spontaneous adverse drug reaction reporting. Drug Saf 2011;34:849-59. [Ref.ID 91173]
10.
Fraser IS, Porte RJ, Kouides PA, Lukes AS. A benefit-risk review of systemic haemostatic agents: Part 1: in major surgery. Drug Saf 2007;31:199-215. [Ref.ID 82458]
12. Cita con resumen
Fuccio L, Minardi ME, Zagari RM, Grilli D, Magrini N, Bazzoli F. Meta-analysis: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication. Ann Intern Med 2007;147:553-62. [Ref.ID 81288]
13.
de Groot MCH, van Puijenbroek EP. Clindamycin and taste disorders. Br J Clin Pharmacol 2007;64:542-5. [Ref.ID 81179]
15.
Sadasivam B, Jhaj R. Dysgeusia with amlodipine - a case report. Br J Clin Pharmacol 2007;63:253. [Ref.ID 79134]
16.
Young TM, Mathias CJ. Taste and smell disturbance with the alfa-adrenoceptor agonist midodrine. Ann Pharmacother 2004;38:1868-70. [Ref.ID 71791]
17.
Tsuruoka S, Wakaumi M, Nishiki K, Araki N, Harada K, Sugimoto K, Fujimora A. Subclinical alteration of taste sensitivity induced by candesartan in healthy subjects. Br J Clin Pharmacol 2004;57:807-12. [Ref.ID 70377]
18.
Berthold HK, Tiaden JD, Hoffler D, Müller-Oerlinghausen B. Frequency of drug-induced taste disorders in the German pharmacovigilance database. Pharmacoepidemiol Drug Saf 2003;12:210S-1S. [Ref.ID 68698]
19. Cita con resumen
Matienzo DS, Gimeno V, Castellsagué J, Arana A. Safety profile analysis of smell and taste disorders in patients treated with COX-2 specific inhibitors and other selected drugs. Pharmacoepidemiol Drug Saf 2003;12:S180-1. [Ref.ID 67139]
20.
Giroldini R. Alterazioni del gusto e dell'olfatto indotte da farmaci. Informazioni sui Farmaci 2003;27:54-6. [Ref.ID 64616]
Seleccionar todas
 
 1 a 20 de 31 siguiente >>